Literature DB >> 14509504

Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Mitsuo Tachibana1, Shoichi Kinugasa, Hiroshi Yoshimura, Dipok Kumar Dhar, Shuhei Ueda, Toshiyuki Fujii, Hitoshi Kohno, Naofumi Nagasue.   

Abstract

Fibrin glue has been shown to be effective in improving postoperative chylothorax following various thoracic procedures and in reducing lymphorrhea after axillary dissection. It is unknown, however, whether fibrin glue is effective in reducing lymph leakage (pleural effusion) after esophagectomy. A series of 43 consecutive patients with thoracic esophageal cancer who underwent extended esophagectomy were prospectively randomized to two groups: group A (n = 21), in whom 3 ml of fibrin glue was applied to the dissected mediastinum; and group B (n = 22), in whom fibrin glue was not applied. The time of drain removal and the volume of the thoracic drainage were compared. All data were expressed as the mean +/- standard deviation. There were no significant differences in the clinicopathologic characteristics between the two groups. None of the patients developed chylothorax or died during their hospital stay. The daily volume from the thoracic drain (457 +/- 273 ml) was significantly (p < 0.05) larger on postoperative day (POD) 1 in group A than in group B (298 +/- 158 ml) and tended to be larger (p < 0.10) on PODs 4 and 6 in group A than in group B. The cumulative drainage volume was significantly (p < 0.05) larger on PODs 4 to 6 and POD 9, and it tended to be larger (p < 0.10) on PODs 1, 3, 7, 8, 10, and 11 in group A than in group B, suggesting that the cumulative drainage volume in group A was consistently larger than that in group B. The cumulative numbers of patients with a drain remaining in place were not significantly different for the two groups (p = 0.4683). Three patients in group A, however, had prolonged insertion (> 20 days) of the chest tube. There were no significant differences in the incidence of postoperative chest-related complications. No patients in group A developed viral infectious disease during the long-term follow-up. Application of fibrin glue to the dissected mediastinum seems to induce postoperative lymph leakage and thus be responsible for prolonged chest tube insertion in some patients. Hence the use of fibrin glue cannot be recommended for reducing lymph leakage after esophagectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14509504     DOI: 10.1007/s00268-003-6989-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

Review 1.  Fibrin sealants in surgical practice: An overview.

Authors:  M R Jackson
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

2.  Chylothorax after thoracoscopic esophagectomy.

Authors:  M Takemura; H Osugi; T Tokuhara; H Kinoshita; M Higashino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-04

3.  Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial.

Authors:  F N Gilly; Y François; A C Sayag-Beaujard; O Glehen; A Brachet; J Vignal
Journal:  Eur Surg Res       Date:  1998       Impact factor: 1.745

4.  Postoperative chylothorax.

Authors:  R J Cerfolio; M S Allen; C Deschamps; V F Trastek; P C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

5.  Transhiatal esophagectomy for carcinoma of the esophagus: experience with 26 patients.

Authors:  J R Hankins; J E Miller; S Attar; J S McLaughlin
Journal:  Ann Thorac Surg       Date:  1987-08       Impact factor: 4.330

6.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

7.  Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.

Authors:  H Kato; Y Tachimori; H Watanabe; H Igaki; Y Nakanishi; A Ochiai
Journal:  J Surg Oncol       Date:  1996-04       Impact factor: 3.454

8.  Esophageal resection and by-pass: a 6 year experience with a low postoperative mortality.

Authors:  J M Collard; J B Otte; M Reynaert; L Michel; M A Carlier; P J Kestens
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

9.  Treatment of postsurgical chylothorax with fibrin glue.

Authors:  W Stenzl; B Rigler; K H Tscheliessnigg; A Beitzke; H Metzler
Journal:  Thorac Cardiovasc Surg       Date:  1983-02       Impact factor: 1.827

10.  Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.

Authors:  M Tachibana; S Kinugasa; D K Dhar; H Tabara; R Masunaga; T Kotoh; H Kubota; N Nagasue
Journal:  Arch Surg       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.